These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16095157)

  • 1. [Experimental methods in the treatment of multiple sclerosis--new possibilities and hopes].
    Szczepanik M; Tutaj M; Filipczak-Bryniarska I; Bryniarski K
    Przegl Lek; 2005; 62(2):115-8. PubMed ID: 16095157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quinpramine: revival of old anti-inflammatory principles in multiple sclerosis?
    Haghikia A; Gold R
    Exp Neurol; 2009 Jun; 217(2):240-1. PubMed ID: 19361499
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunopathogenesis of multiple sclerosis.
    Agrawal SM; Yong VW
    Int Rev Neurobiol; 2007; 79():99-126. PubMed ID: 17531839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy in multiple sclerosis.
    Milo R; Panitch H
    J Neuroimmunol; 2011 Feb; 231(1-2):23-31. PubMed ID: 21111490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunopathogenesis and immunotherapy of multiple sclerosis.
    Hemmer B; Nessler S; Zhou D; Kieseier B; Hartung HP
    Nat Clin Pract Neurol; 2006 Apr; 2(4):201-11. PubMed ID: 16932551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New treatments for multiple sclerosis].
    Masdeu JC
    Rev Neurol; 1996 Jun; 24(130):708-11. PubMed ID: 8653621
    [No Abstract]   [Full Text] [Related]  

  • 7. Central nervous system effects of current and emerging multiple sclerosis-directed immuno-therapies.
    Antel JP; Miron VE
    Clin Neurol Neurosurg; 2008 Nov; 110(9):951-7. PubMed ID: 18502570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AANA Journal course: update for nurse anesthetists--an overview of multiple sclerosis and implications for anesthesia.
    Schneider KM
    AANA J; 2005 Jun; 73(3):217-24. PubMed ID: 16010775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The future of multiple sclerosis treatment.
    Cohen JA
    J Neurol Sci; 2009 Feb; 277 Suppl 1():S55-61. PubMed ID: 19200869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of worsening multiple sclerosis with mitoxantrone: a review.
    Fox EJ
    Clin Ther; 2006 Apr; 28(4):461-74. PubMed ID: 16750460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoids in the control of neuroinflammation.
    Tischner D; Reichardt HM
    Mol Cell Endocrinol; 2007 Sep; 275(1-2):62-70. PubMed ID: 17555867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic and symptomatic treatment of multiple sclerosis.
    Rosenblum D; Saffir M
    Phys Med Rehabil Clin N Am; 1998 Aug; 9(3):587-601, vi-vii. PubMed ID: 9894111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modern multiple sclerosis treatment - what is approved, what is on the horizon.
    Pilz G; Wipfler P; Ladurner G; Kraus J
    Drug Discov Today; 2008 Dec; 13(23-24):1013-25. PubMed ID: 18775508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of glatiramer acetate in the treatment of multiple sclerosis.
    Wolinsky JS
    Adv Neurol; 2006; 98():273-92. PubMed ID: 16400839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinician's approach to modulate disease activity in MS.
    Cook SD
    Rev Neurol Dis; 2005; 2(3):117-23. PubMed ID: 16400310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacologic constraints imposed by the blood-brain barrier: the example of multiple sclerosis].
    Jolliet P
    Rev Neurol (Paris); 2000 Jul; 156(6-7):681-3. PubMed ID: 10891808
    [No Abstract]   [Full Text] [Related]  

  • 17. Curcumin has bright prospects for the treatment of multiple sclerosis.
    Xie L; Li XK; Takahara S
    Int Immunopharmacol; 2011 Mar; 11(3):323-30. PubMed ID: 20828641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Multiple sclerosis: a multi-specific immune deficiency disease].
    Lamoureux G; Toupin J; Leyva F
    Ann Immunol (Paris); 1977; 128(1-2):531-6. PubMed ID: 848902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The challenge of managing patients with multiple sclerosis.
    MacLean R
    Nurs Times; 2004 Jan 27-Feb 2; 100(4):42-4. PubMed ID: 14974264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glatiramer acetate: mechanisms of action in multiple sclerosis.
    Ziemssen T; Schrempf W
    Int Rev Neurobiol; 2007; 79():537-70. PubMed ID: 17531858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.